Skip to content

Eris Lifesciences trades lower after buying branded formulation business of Biocon Biologics

Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930.

Read More

​ Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930. Broking house Motilal Oswal maintained neutral on Eris Lifesciences with a price target of Rs 930.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish